Calumet, Inc. (NASDAQ: CLMT) has announced that Jennifer G. Straumins, a member of its Board of Directors, will not seek re-election and will retire at the end of her current term, which concludes at the Company's 2026 Annual Meeting of Stockholders. This decision was communicated to the Board on March 23, 2026. The company emphasized that her retirement is not due to any disagreements regarding the operations, policies, or practices of Calumet. Straumins has been a significant part of the Board since July 2024 and has previously served on the board of Calumet GP, LLC from February 2021 to July 2024. She has also been an employee of the Partnership for 13 years, contributing her extensive experience in specialty products to the Board's Strategy and Growth and Risk Committees. In a statement, Steve Mawer, Chair of the Board, expressed gratitude for Straumins' dedicated service and valuable contributions, highlighting her impact on the company's strategic direction. Todd Borgmann, CEO, also acknowledged her leadership and support, noting that her efforts have laid a strong foundation for Calumet's future growth. The Board will continue to assess its composition and skills to align with the company's strategic goals and governance best practices. This transition is expected to be smooth, with the Nominating and Governance Committee actively involved in the process. The company remains committed to executing its growth strategy and building on the legacy left by Straumins.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.